{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Proliferating Pilar Tumors Are Characterized by Recurrent 15q, 6q, and 6p22.2 Alterations ((Non-Physician Credit))

Activity Steps


The certificate for this activity is for NON-PHYSICIANS.

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe the clinicopathologic features of proliferating pilar tumors.
  2. Explain the cytogenetic alterations involved in the pathogenesis of proliferating pilar tumors.
  3. Differentiate the pathogenesis of proliferating pilar tumors from cutaneous squamous cell carcinoma.
Price: $15.00


  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Test Code: AJDN0423
Published: April 2023
Expires: 3/31/2025
Required Passing Score: 4/5 (80%)
Authors: Grant M. Fischer, MD, PhD, Neal I. Lindeman, MD, Azra H. Ligon, PhD, and Eleanor Russell-Goldman, MD, PhD
Categories: Dermatology , Pathology